Two Seas Capital LP Roivant Sciences Ltd. Transaction History
Two Seas Capital LP
- $195 Million
- Q1 2024
A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 7,930,349 shares of ROIV stock, worth $85.9 Million. This represents 42.9% of its overall portfolio holdings.
Number of Shares
7,930,349
Previous 8,508,223
6.79%
Holding current value
$85.9 Million
Previous $95.5 Million
12.52%
% of portfolio
42.9%
Previous 50.66%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
265Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$791 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$751 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$723 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$392 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$386 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.63B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...